Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs AJANTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA AJANTA PHARMA SANOFI INDIA/
AJANTA PHARMA
 
P/E (TTM) x 31.0 38.3 81.0% View Chart
P/BV x 15.4 8.3 185.2% View Chart
Dividend Yield % 7.0 0.3 2,244.9%  

Financials

 SANOFI INDIA   AJANTA PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-22
AJANTA PHARMA
Mar-23
SANOFI INDIA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs7,9391,426 556.8%   
Low Rs5,4541,062 513.5%   
Sales per share (Unadj.) Rs1,202.8297.2 404.7%  
Earnings per share (Unadj.) Rs269.546.7 577.1%  
Cash flow per share (Unadj.) Rs287.757.1 503.9%  
Dividends per share (Unadj.) Rs570.007.00 8,142.9%  
Avg Dividend yield %8.50.6 1,512.7%  
Book value per share (Unadj.) Rs527.0269.1 195.9%  
Shares outstanding (eoy) m23.03125.91 18.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.64.2 133.0%   
Avg P/E ratio x24.926.6 93.3%  
P/CF ratio (eoy) x23.321.8 106.8%  
Price / Book Value ratio x12.74.6 274.8%  
Dividend payout %211.515.0 1,411.1%   
Avg Mkt Cap Rs m154,224156,638 98.5%   
No. of employees `000NANA-   
Total wages/salary Rs m4,0597,851 51.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,70137,426 74.0%  
Other income Rs m730986 74.0%   
Total revenues Rs m28,43138,413 74.0%   
Gross profit Rs m8,3497,833 106.6%  
Depreciation Rs m4191,308 32.0%   
Interest Rs m1758 29.1%   
Profit before tax Rs m8,6437,453 116.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4371,573 155.0%   
Profit after tax Rs m6,2065,880 105.5%  
Gross profit margin %30.120.9 144.0%  
Effective tax rate %28.221.1 133.6%   
Net profit margin %22.415.7 142.6%  
BALANCE SHEET DATA
Current assets Rs m36,12128,252 127.9%   
Current liabilities Rs m27,42511,393 240.7%   
Net working cap to sales %31.445.0 69.7%  
Current ratio x1.32.5 53.1%  
Inventory Days Days11766 177.3%  
Debtors Days Days1710 165.0%  
Net fixed assets Rs m12,14818,707 64.9%   
Share capital Rs m230253 91.0%   
"Free" reserves Rs m11,90633,624 35.4%   
Net worth Rs m12,13633,877 35.8%   
Long term debt Rs m013 0.0%   
Total assets Rs m48,27947,047 102.6%  
Interest coverage x509.4128.6 396.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.8 72.1%   
Return on assets %12.912.6 102.1%  
Return on equity %51.117.4 294.6%  
Return on capital %71.422.2 322.0%  
Exports to sales %14.159.9 23.5%   
Imports to sales %14.611.5 127.0%   
Exports (fob) Rs m3,90422,420 17.4%   
Imports (cif) Rs m4,0374,293 94.0%   
Fx inflow Rs m3,90422,420 17.4%   
Fx outflow Rs m4,0374,293 94.0%   
Net fx Rs m-13318,127 -0.7%   
CASH FLOW
From Operations Rs m3,9877,918 50.4%  
From Investments Rs m6,509-5,596 -116.3%  
From Financial Activity Rs m-15,827-1,079 1,467.2%  
Net Cashflow Rs m-5,3311,243 -428.8%  

Share Holding

Indian Promoters % 0.0 66.2 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 28.8 25.8 111.8%  
FIIs % 6.3 9.1 69.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 33.8 117.2%  
Shareholders   62,870 54,351 115.7%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Sanofi India vs AJANTA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sanofi India vs AJANTA PHARMA Share Price Performance

Period Sanofi India AJANTA PHARMA S&P BSE HEALTHCARE
1-Day 2.06% 2.51% 1.18%
1-Month -8.09% 7.60% -0.75%
1-Year 44.45% 92.91% 61.82%
3-Year CAGR 0.97% 21.63% 18.16%
5-Year CAGR 7.07% 26.85% 19.79%

* Compound Annual Growth Rate

Here are more details on the Sanofi India share price and the AJANTA PHARMA share price.

Moving on to shareholding structures...

The promoters of Sanofi India hold a 60.4% stake in the company. In case of AJANTA PHARMA the stake stands at 66.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sanofi India and the shareholding pattern of AJANTA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Sanofi India paid a dividend of Rs 570.0 per share. This amounted to a Dividend Payout ratio of 211.5%.

AJANTA PHARMA paid Rs 7.0, and its dividend payout ratio stood at 15.0%.

You may visit here to review the dividend history of Sanofi India, and the dividend history of AJANTA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.